You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TLR

Showing 1 - 25 of 1,554
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome

Completed
  • Congenital Heart Disease
  • +6 more
  • ToF primary repair
  • Jakarta, Indonesia
    National Cardiovascular Center Harapan Kita Jakarta Indonesia
Aug 4, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

All Types of Solid Cancer Trial in Bron, Pierre Benite, Pierre-Bénite (Blood sampling)

Not yet recruiting
  • All Types of Solid Cancer
  • Blood sampling
  • Bron, France
  • +3 more
Nov 8, 2023

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Peripheral Arterial Disease Trial in Shanghai

Recruiting
  • Peripheral Arterial Disease
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Oct 26, 2022

    Sun Damaged Skin Trial in Tucson (Solar Simulated Light (SSL))

    Recruiting
    • Sun Damaged Skin
    • Solar Simulated Light (SSL)
    • Tucson, Arizona
      University of Arizona
    Jun 1, 2022

    Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)

    Active, not recruiting
    • Advanced Cancers
    • Melanoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 11, 2022

    HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

    Not yet recruiting
    • HIV Infections
    • sD-NP-GT8 DNA
    • +4 more
    • Birmingham, Alabama
    • +5 more
    Mar 10, 2023

    TLR4 Polymorphisms and Risk of Skin Cancer

    Active, not recruiting
    • Skin Cancer
    • Detection of single nucleotide polymorphisms (SNP)
    • Birmingham, Alabama
      The Kirklin Clinic
    Jan 20, 2022

    Melanoma Trial in Pittsburgh (drug, biological, other)

    Recruiting
    • Melanoma
    • Vidutolimod (CMP-001)
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 25, 2022

    Biomarkers of Trained Immunity Following MMR Vaccination

    Completed
    • Covid19
    • Heterologous stimuli
    • Neutralization assay
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 24, 2021

    Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

    Recruiting
    • Advanced Solid Tumor
    • +7 more
    • TransCon IL-2 β/γ
    • +4 more
    • Boston, Massachusetts
    • +7 more
    Nov 16, 2022

    Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

    Recruiting
    • Advanced Solid Tumor
    • +6 more
    • Duarte, California
    • +12 more
    Sep 21, 2022

    Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

    Completed
    Has Results
    • Breast Cancer
    • +2 more
    • Radiation
    • +2 more
    • New York, New York
      New York University Medical Center
    Oct 25, 2021

    Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

    Not yet recruiting
    • Spondylitis
    • Tuberculosis
    • 400 IU
    • +3 more
    • Makassar, South Sulawesi, Indonesia
      Wahidin Sudirohusodo General Hospital
    May 11, 2022

    HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

    Recruiting
    • HIV-1-infection
    • Umlazi, South Africa
      FRESH Clinical Research Site: Females Rising through Education,
    Jan 4, 2023

    Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

    Completed
    Has Results
    • Melanoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jul 20, 2021

    Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation

    Active, not recruiting
    • Grade 1 Follicular Lymphoma
    • +6 more
    • Palo Alto, California
      Stanford University, School of Medicine
    Jun 13, 2022

    Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

    Completed
    • Carcinoma, Hepatocellular
    • +3 more
    • Duarte, California
    • +9 more
    Jan 27, 2023

    CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations

    Completed
    • Cystic Fibrosis
      • Denver, Colorado
        National Jewish Health
      Aug 31, 2021

      B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

      Active, not recruiting
      • B-Cell Non-Hodgkin Lymphoma
      • +7 more
      • Anti-OX40 Antibody BMS 986178
      • +3 more
      • Palo Alto, California
        Stanford University, School of Medicine
      May 3, 2022

      Advanced Cancer Trial in Villejuif (Ipilimumab, Nivolumab, Tilsotolimod)

      Active, not recruiting
      • Advanced Cancer
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Jul 21, 2021